Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)

NCT05331144 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Cognitively Normal Older Adults
Hypertension
Subjective Cognitive Decline
Family History of Dementia

Interventions

DRUG: Angiotensin II Receptor Blockers (ARBs, losartan) and Calcium Channel Blockers (CCB, amlodipine)
OTHER: PCP

Sponsor

Rong Zhang

Collaborators

[object Object]
[object Object]
[object Object]